Related Experiment Videos
Tuberculosis and lung cancer. An interesting case study
F Mariani1, M Bocchino, G Cappelli
1Experimental Medicine Institute-CNR, Rome, Italy.
Summary
Tuberculosis infection may trigger an immune response against lung cancer. Researchers observed Mycobacterium tuberculosis-infected T-lymphocytes attacking tumor cells in vitro, suggesting a novel therapeutic avenue.
Area of Science:
- Immunology
- Oncology
- Infectious Diseases
Background:
- The bacillus Calmette-Guerin (BCG) vaccine, a weakened form of Mycobacterium bovis, demonstrates efficacy in treating certain cancers.
- The potential for other Mycobacterium tuberculosis infections to elicit anti-tumor responses remains largely unexplored.
Observation:
- A lung cancer patient experienced complete tumor remission during a concurrent tuberculosis infection.
- In vitro studies involved culturing T-lymphocytes from the patient, infected with M. tuberculosis, alongside lung tumor cell lines.
Findings:
- Cultured T-lymphocytes demonstrated adherence to tumor cells, which subsequently showed a reduction in number.
- M. tuberculosis significantly induced nitric oxide synthase expression in infected macrophages, a mechanism potentially regulating cytotoxic activity.
Implications:
- Mycobacterium tuberculosis infection may stimulate a potent anti-cancer immune response.
- This observation opens avenues for exploring M. tuberculosis or its components as potential immunotherapies for lung cancer.
- Further research is warranted to elucidate the precise mechanisms of this anti-tumor activity.